Navigation Links
Aratana to Participate in Leerink Swann's November Management Access Days

KANSAS CITY, Kan. and NEW YORK, Nov. 12, 2012 /PRNewswire/ -- Aratana Therapeutics, a biopharmaceutical company developing innovative medicines for cats and dogs (companion animals), today announced that it will participate in Leerink Swann's November Management Access Days, taking place November 19 - 20, 2012, at Leerink Swann's headquarters in Boston, Massachusetts. 

On November 19, 2012, Steven St. Peter, M.D., President and Chief Executive Officer of Aratana, will host one-on-one meetings with investors.  He will be joined by Louise Mawhinney, CPA, Chief Financial Officer, and Linda Rhodes, V.M.D., Ph.D., Chief Scientific Officer of Aratana Therapeutics. 

About Aratana Therapeutics

Aratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).  Aratana licenses and develops proprietary, patent-protected compounds acquired from human pharmaceutical and biotechnology companies and then develops strategies to maximize the value of the programs for the animal health market.  For more information, please visit

For Media & Investors:
Jason Rando / Joshua Drumm, Ph.D.
Tiberend Strategic Advisors, Inc.
(212) 827-0020


SOURCE Aratana Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Uroplasty To Participate In Two Upcoming Investor Conferences
2. CryoLife to Participate in Lazard Capital Markets 9th Annual Healthcare Conference
3. Mindray Medical to Participate in MEDICA 2012 in Dusseldorf, Germany
4. MedNet Solutions To Sponsor And Participate In The 2012 SCDM Annual Conference
5. Acceliant Participates as Platinum Sponsor at the SCDM Annual Conference in Los Angeles
6. Camfil Farr to Sponsor, Participate in Premier Pharma Manufacturing Conference
7. Boston Scientific to Participate in the 2012 Morgan Stanley Global Healthcare Conference
8. Cyberonics To Participate In Upcoming September Investor Conferences
9. Henry Schein to Participate in the 5th Annual Barrington Research Growth Conference
10. Hologic To Participate In The Morgan Stanley Global Healthcare Conference
11. FAME 2 Published in the New England Journal of Medicine, Volcano participates in the $84M NIH-Sponsored ISCHEMIA Trial
Post Your Comments:
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... report to their offering. ... failure, it replaces the function of kidneys by removing the ... the treatment helps to keep the patient body,s electrolytes such ... Increasing number of ESRD patients & substantial healthcare expenditure on ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology:
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from reveals that behind the ...
Breaking Medicine News(10 mins):